Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
77,331,078
-
Total 13F shares
-
4,275,072
-
Share change
-
+3,819,067
-
Total reported value
-
$83,141,000
-
Price per share
-
$19.75
-
Number of holders
-
16
-
Value change
-
+$74,135,921
-
Number of buys
-
13
Institutional Holders of Xenon Pharmaceuticals Inc. - Common Stock (XENE) as of Q4 2014
As of 31 Dec 2014,
Xenon Pharmaceuticals Inc. - Common Stock (XENE) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,275,072 shares.
The largest 10 holders included
FMR LLC, Capital World Investors, BVF INC/IL, Visium Asset Management, LP, Invesco Private Capital, Inc., EcoR1 Capital, LLC, PERCEPTIVE ADVISORS LLC, Novo A/S, ROYAL BANK OF CANADA, and CAISSE DE DEPOT ET PLACEMENT DU QUEBEC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.